We have used the technique of in situ hybridization to investigate the expression of lymphokine genes by immature thymocytes during intrathymic development. In 13-day fetal thymocytes a population of cells constitutively produces low levels of interleukin 2 (IL-2) and interleukin 4 (IL-4) mRNAs. A second phase of lymphokine gene expression occurs in the majority of 15-day thymocytes, and a population of cells constitutively produces both IL-2 and IL-4 mRNAs. Thymocytes at 14 days of gestation and after 16 days up until birth do not express detectable lymphokine mRNA. By contrast, the population of IL-2 receptor mRNA-producing thymocytes increases progressively up to 15 days of gestation, and expression thereafter decreases up to birth. In addition, thymocytes expressing interferon y mRNA were not present until just prior to birth. Our fmdings indicate developmental control of lymphokine and lymphokine receptor gene expression in fetal thymocytes during ontogeny.A central issue of T-cell ontogeny is the identification of the signals and growth factors required for the proliferation and differentiation of immature cells in the thymus. Studies seeking to examine this issue by measuring the production and use of growth factors by thymocytes have depended on the stimulation of these cells by phorbol esters and ionophores outside the thymic environment (1-5). These results may not be representative ofevents inside the intact organ for several reasons. First, the activating agents are not physiological, and second, cells stimulated in this way do not undergo normal maturation or full T-cell receptor gene rearrangement. In addition, the development of thymocytes within the thymus may in part be dependent upon the coordinated production of growth factors by different populations of cells throughout ontogeny. Thus, the use of such potent stimulating agents as phorbol esters and ionophores to induce lymphokine production by immature thymocytes in vitro may mask or abrogate the regulated production of these growth factors by thymocytes that would occur in vivo.